Henry Schein, Inc.

HSIC

$90.39

+2.11%

2026-09-02 16:00:01 EDT+$1.87

Healthcare

Medical - Distribution

NASDAQ

Active Trading

Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to ...

Price Action of HSIC

$90.39

+2.11%+$1.87

High—

Low—

52W High-1.9%

Rel. vol—

Interval

Range6.5h

Volume—SMA5SMA10

—

Henry Schein, Inc. (HSIC) is a global leader in healthcare solutions, headquartered in Melville, New York, and founded in 1932 by Henry and Esther Schein as a storefront pharmacy in Queens. As of 2025, the company employs over 25,000 people and serves more than 1 million customers worldwide, including dental ...Henry Schein, Inc. (HSIC) is a global leader in healthcare solutions, headquartered in Melville, New York, and founded in 1932 by Henry and Esther Schein as a storefront pharmacy in Queens. As of 2025, the company employs over 25,000 people and serves more than 1 million customers worldwide, including dental and medical practices, laboratories, governmental institutions, and other healthcare facilities. The company operates through two primary segments: Health Care Distribution and Technology and Value-Added Services. The Health Care Distribution segment offers a comprehensive range of dental consumables (infection control products, impression materials, composites, anesthetics, artificial teeth), equipment (handpieces, chairs, X-ray systems, digital restoration systems), personal protective equipment, and repair services. It also distributes medical supplies such as branded and generic pharmaceuticals, vaccines, surgical instruments, diagnostic kits, imaging products, and nutritional supplements. The Technology and Value-Added Services segment provides practice management software, financial services (non-recourse financing), electronic services, technology infrastructure support, hardware services, professional education, and consulting. Financially, the company reported revenue of $13.2 billion in 2025, with a net income of $398 million. Key financial metrics include a gross profit margin of 30.3%, an operating profit margin of 5.7%, and a net profit margin of 3.0%. The company has a market capitalization of approximately $10 billion as of the provided data. Historically, Henry Schein went public in 1995 and has been led by notable CEOs, including Jay Schein (1978-1989), Stanley Bergman (1989-2026), and Frederick M. Lowery (effective March 2, 2026). The company is committed to its 'Bold+1' strategic plan, focusing on building complementary software, specialty, and services to shift toward higher-growth and higher-margin businesses. Henry Schein's mission is to provide trusted advice and innovative solutions to improve operational excellence and clinical outcomes for healthcare practitioners.ExpandCollapse

Founded

1932

Employees

25000

CEO

Frederick Lowery

Full Name

Henry Schein, Inc.

Sector

Healthcare

Industry

Medical - Distribution

ROE

12.37%

Market Cap

$10.30B

Current Ratio

1.32

WACC

7.08%

ROIC

7.52%

Contact Information

https://www.henryschein.com

631 843 5500

135 Duryea Road, Melville, NY 11747

Key Metrics of HSIC

Snapshot

Latest / TTM · 6 periods

Market Cap

$10.30B

ROCE

9.8%

EV / EBITDA

13.59x

+0.3% YoY

FCF Yield

5.2%

-1.0% YoY

Cash Conversion Cycle

82.9d

Current Ratio

1.32

Quick take

TTM —

Positive CCC

Financial Highlights of HSIC

Profitability trend

Latest / TTM · 6 periods

Gross Margin

30.3%

Net Margin

3.0%

P/E Ratio

26.26x

n/a

Debt / Equity

1.21

n/a

Current Ratio

1.32

Dividend Yield

0.0%

Understanding

TTM —

No major balance sheet stress in these headline ratios.

Calendar of HSIC

Upcoming

Sep 27, 2026In 23 days
Q3 FY2026 · Estimated results
Est. EPS $1.36 · Revenue $3.47B · 12 analysts
Dec 27, 2026
FY2026 · Estimated annual results
Est. EPS $5.38 · Revenue $13.87B · 11 analysts
Mar 27, 2027
Q1 FY2027 · Estimated results
Est. EPS $1.44 · Revenue $3.49B · 9 analysts
Jun 27, 2027
Q2 FY2027 · Estimated results
Est. EPS $1.44 · Revenue $3.58B · 4 analysts

Recent history

Aug 4, 2026
Q2 FY2026 · Results reported
EPS $0.82 · Revenue $3.46B
View filing
May 5, 2026
Q1 FY2026 · Results reported
EPS $0.92 · Revenue $3.37B
View filing
Feb 24, 2026
FY2025 · Annual results
EPS $3.27 · Revenue $13.18B
View filing
Nov 4, 2025
Q3 FY2025 · Results reported
EPS $0.84 · Revenue $3.34B
View filing
Aug 5, 2025
Q2 FY2025 · Results reported
EPS $0.70 · Revenue $3.24B
View filing
May 5, 2025
Q1 FY2025 · Results reported
EPS $0.88 · Revenue $3.17B
View filing

Financial Statements of HSIC

5Y Trend (Revenue, Earnings, FCF)

Metric	Latest	YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength.	QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes.
RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three).	$13.2B	+4.0%	+2.7%
Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day.	$398.0M	+2.1%	-12.1%
Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials.	+29.1%	-1.9%	+0.2%
Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on).	+5.7%	-0.1%	+7.0%
Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales.	+3.0%	-1.9%	-14.4%
Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock.	$573.0M	-13.3%	+244.1%
FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine.	+4.3%	-16.7%	+240.4%
Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe.	113.6%	+34.3%	+5.2%
Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking.	1.38x	-2.7%	-3.3%
Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground.	$11.2B	+9.8%	+0.7%

Actual vs Estimate

A Dec 27Q Sep 27

Metric	Annual (A vs E)	Annual Surprise	Quarter (A vs E)	Quarter Surprise
EPS Surprise	3.27 vs 4.92	-33.5%	0.82 vs 1.36	-39.7%
Revenue Surprise	$13.2B vs $13.1B	+0.7%	$3.5B vs $3.5B	-0.4%

Insider Transactions of HSIC

Acquisitions (A)

Since Mar 19, 2026

Disposals (D)

Since Mar 19, 2026

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Insider Trading Snapshot

Date	Executive	Title	Security	Side	Shares	Price
Jun 12, 2026	DANIEL WILLIAM K	director	Common Stock, par value $0.01 per share	A	2,215	—
May 26, 2026	BERGMAN STANLEY M	other: Former Director	Common Stock, par value $0.01 per share	D	50	—
May 21, 2026	Murphy Kelly Ann	officer: SVP & General Counsel	Common Stock, par value $0.01 per share	—	0	—
May 21, 2026	Murphy Kelly Ann	officer: SVP & General Counsel	Stock Option (Right to Buy)	—	1,479	$62.71
May 21, 2026	Murphy Kelly Ann	officer: SVP & General Counsel	Stock Option (Right to Buy)	—	9,274	$76.76

Earnings Call Transcript of HSIC

1 transcript segments

Q2 2026

Unknown Speaker

Operator: Good morning, ladies and gentlemen, and welcome to Henry Schein's Second Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded. I would now like to introduce your host for today's call, Graham Stanley, Henry Schein's Vice President of Investor Relations and Strategic Financial Project Officer. Please go ahead, Graham. Graham Stanley: Thank you, operator, and my thanks to each of you for joining us to discuss Henry Schein's financial results for the second quarter of 2026. With me on today's call are Fred Lowery, Chief Executive Officer; and Ron South, Senior Vice President and Chief Financial Officer. Before we begin, I'd like to state that certain comments made during this call will include information that is forward-looking. Risks and uncertainties involved in the company's business may affect the matters referred to in forward-looking statements, and the company's performance may materially differ from those expressed in or indicated by such statements. These forward-looking statements are qualified in their entirety by the cautionary statements contained in Henry Schein's filings with the Securities and Exchange Commission and included in the Risk Factors section of those filings. In addition, all comments about the markets we serve, including end market growth rates and market share, are based upon the company's internal analysis and estimates. Today's remarks will include both GAAP and non-GAAP financial results. We believe the non-GAAP financial measures provide investors with useful supplemental information about the financial performance of our business, enable the comparison of financial results between periods where certain items may vary independently of business performance and allow for greater transparency with respect to key metrics used by management in operating our business. These non-GAAP financial measures are presented solely for informational and comparative purposes and should not be regarded as a replacement for corresponding GAAP measures. Reconciliations between GAAP and non-GAAP measures are included in Exhibit B of today's press release and can be found in the Financials and Filings section of our Investor Relations website under the Supplemental Information heading and also in our quarterly earnings presentation also posted on our Investor Relations website. The content of this conference call contains time-sensitive information that is accurate only as of the date of the live broadcast, August 4, 2026. Henry Schein undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this call. Lastly, during today's Q&A session, please limit yourself to a single question so that we can accommodate questions for as many as you as possible. And with that, I'd like to turn the call over to Fred Lowery. Frederick Lowery: Thank you, Graham. Good morning, everyone, and thank you for joining us. I'm …

Leadership Team of HSIC

10 executives

Name	Title	Compensation	Gender	Year Born	Status
Andrea Albertini	Chief Executive Officer of Global Distribution & Technology	USD 1,767,196	Male	1970	Active
Mark E. Mlotek	Executive Vice President & Chief Strategic Officer	USD 1,687,571	Male	1956	Active
Michael Saul Ettinger	Executive Vice President & Chief Operating Officer	USD 1,433,227	Male	1961	Active
Ronald N. South	Senior Vice President & Chief Financial Officer	USD 1,177,296	Male	1962	Active
Christopher Pendergast	Senior Vice President & Chief Technology Officer	—	Male	1963	Active
Graham Stanley	Vice President of Investor Relations & Strategic Finance Project Officer	—	Male	—	Active
Christine Sheehy	Senior Vice President & Chief Human Resources Officer	—	Female	1968	Active
Kelly Murphy	Senior Vice President & General Counsel	—	Female	1981	Active
Olga Timoshkina	VP of Corporate Finance & Chief Accounting Officer	—	Female	—	Active
Frederick Lowery	CEO & Director	—	Male	1971	Active

Recent News of HSIC

Zacks Investment Research22 hours agoNeutral

Henry Schein (HSIC) is an Incredible Growth Stock: 3 Reasons Why

Henry Schein (HSIC) could produce exceptional returns because of its solid growth attributes.

Zacks Investment Research23 hours agoNeutral

Why Is Henry Schein (HSIC) Up 0.9% Since Last Earnings Report?

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research2 days agoNeutral

Why Henry Schein (HSIC) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research2 days agoNeutral

Is Henry Schein (HSIC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Defense World8/28/2026Neutral

505,999 Shares in Henry Schein, Inc. $HSIC Purchased by Bank of New York Mellon Corp

Bank of New York Mellon Corp purchased a new stake in Henry Schein, Inc. (NASDAQ: HSIC) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 505,999 shares of the company's stock, valued at approximately $42,261,000. Bank of New York

Historical Employee Count of HSIC

Current

25,000

Change

+0.00%

Minimum

21,600

Maximum

25,000

Recent Filings

Report Date	Employees	Form Type	Filing Date	SEC Filing
Dec 27, 2025	25,000	10-K	Feb 24, 2026	View
Dec 28, 2024	25,000	10-K	Feb 25, 2025	View
Dec 30, 2023	25,000	10-K	Feb 28, 2024	View
Dec 31, 2022	22,000	10-K	Feb 21, 2023	View
Dec 25, 2021	21,600	10-K	Feb 15, 2022	View

Related stocksMedical - Distribution

Browse all US stocks →

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

Henry Schein, Inc.